US FDA issues three observations after Alembi's Panelav formulations facility

21 Mar 2018

1

Alembic Pharmaceuticals Ltd on Wednesday said that the US health regulator inspected its formulation facility at Panelav in Gujarat and made three observations, none of which are related to dat integrity or repetitive in nature.

“The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals formulation facility located at Panelav from March 12-20, 2018. This was a scheduled inspection and at the end of the inspection, the USFDA issued a form 483 with 3 observations,” the company said in a regulatory filing.
It added, “The company is preparing the response to the observations, which will be submitted to the USFDA shortly,” it added.
The USFDA issues a Form 483 at the conclusion of an inspection when its investigators observe any conditions that in its judgement may violate the Food Drug and Cosmetic (FD&C) Act and related Acts.
Alembic has  formulations facilities at Vadodara, Panelav and Baddi.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers